365 related articles for article (PubMed ID: 16567505)
1. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation.
Guigas B; Bertrand L; Taleux N; Foretz M; Wiernsperger N; Vertommen D; Andreelli F; Viollet B; Hue L
Diabetes; 2006 Apr; 55(4):865-74. PubMed ID: 16567505
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
Mukhtar MH; Payne VA; Arden C; Harbottle A; Khan S; Lange AJ; Agius L
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R766-74. PubMed ID: 18199594
[TBL] [Abstract][Full Text] [Related]
3. 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside reduces glucose uptake via the inhibition of Na+/H+ exchanger 1 in isolated rat ventricular cardiomyocytes.
Ségalen C; Longnus SL; Baetz D; Counillon L; Van Obberghen E
Endocrinology; 2008 Apr; 149(4):1490-8. PubMed ID: 18187546
[TBL] [Abstract][Full Text] [Related]
4. The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading.
Jørgensen SB; Nielsen JN; Birk JB; Olsen GS; Viollet B; Andreelli F; Schjerling P; Vaulont S; Hardie DG; Hansen BF; Richter EA; Wojtaszewski JF
Diabetes; 2004 Dec; 53(12):3074-81. PubMed ID: 15561936
[TBL] [Abstract][Full Text] [Related]
5. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
[TBL] [Abstract][Full Text] [Related]
6. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
[TBL] [Abstract][Full Text] [Related]
7. AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC.
Sajan MP; Bandyopadhyay G; Miura A; Standaert ML; Nimal S; Longnus SL; Van Obberghen E; Hainault I; Foufelle F; Kahn R; Braun U; Leitges M; Farese RV
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E179-92. PubMed ID: 19887597
[TBL] [Abstract][Full Text] [Related]
8. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle.
Li J; Hu X; Selvakumar P; Russell RR; Cushman SW; Holman GD; Young LH
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E834-41. PubMed ID: 15265762
[TBL] [Abstract][Full Text] [Related]
9. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
Salt IP; Connell JM; Gould GW
Diabetes; 2000 Oct; 49(10):1649-56. PubMed ID: 11016448
[TBL] [Abstract][Full Text] [Related]
10. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion.
Bradley EA; Eringa EC; Stehouwer CD; Korstjens I; van Nieuw Amerongen GP; Musters R; Sipkema P; Clark MG; Rattigan S
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1137-42. PubMed ID: 20224051
[TBL] [Abstract][Full Text] [Related]
11. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
12. AMPKα2 translocates into the nucleus and interacts with hnRNP H: implications in metformin-mediated glucose uptake.
Kim N; Lee JO; Lee HJ; Lee SK; Moon JW; Kim SJ; Park SH; Kim HS
Cell Signal; 2014 Sep; 26(9):1800-6. PubMed ID: 24686086
[TBL] [Abstract][Full Text] [Related]
13. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
14. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.
Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS
J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782
[TBL] [Abstract][Full Text] [Related]
15. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
[TBL] [Abstract][Full Text] [Related]
16. 5-aminoimidazole-4-carboxamide-1-beta-ribofuranoside (AICAR) prevents nuclear translocation of constitutive androstane receptor by AMP-activated protein kinase (AMPK) independent manner.
Kanno Y; Inoue Y; Inouye Y
J Toxicol Sci; 2010 Aug; 35(4):571-6. PubMed ID: 20686344
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase.
Samari HR; Seglen PO
J Biol Chem; 1998 Sep; 273(37):23758-63. PubMed ID: 9726984
[TBL] [Abstract][Full Text] [Related]
18. AMP kinase activation increases glucose uptake, decreases apoptosis, and improves pregnancy outcome in embryos exposed to high IGF-I concentrations.
Eng GS; Sheridan RA; Wyman A; Chi MM; Bibee KP; Jungheim ES; Moley KH
Diabetes; 2007 Sep; 56(9):2228-34. PubMed ID: 17575082
[TBL] [Abstract][Full Text] [Related]
19. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits.
Treebak JT; Glund S; Deshmukh A; Klein DK; Long YC; Jensen TE; Jørgensen SB; Viollet B; Andersson L; Neumann D; Wallimann T; Richter EA; Chibalin AV; Zierath JR; Wojtaszewski JF
Diabetes; 2006 Jul; 55(7):2051-8. PubMed ID: 16804075
[TBL] [Abstract][Full Text] [Related]
20. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling.
Luiken JJ; Coort SL; Willems J; Coumans WA; Bonen A; van der Vusse GJ; Glatz JF
Diabetes; 2003 Jul; 52(7):1627-34. PubMed ID: 12829625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
